{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:54:20Z","timestamp":1791500060687,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Skin of color Society-CDA"},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AR075996"],"award-info":[{"award-number":["1R21AR075996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AR083790-01A1"],"award-info":[{"award-number":["1R01AR083790-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["ZIA AR041199"],"award-info":[{"award-number":["ZIA AR041199"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with complex immune dysregulation. While previous studies have reported tertiary lymphoid structures (TLS) and IgA-producing B cells in HS skin lesions, the pathogenic role of IgA autoantibodies remains insufficiently characterized. Here, we demonstrate that lesional skin from patients with HS exhibits elevated expression of IGHA1, IGHA2, and J chain, as confirmed by qPCR, immunofluorescence, and Western blot analyses. Single-cell RNA sequencing identified local plasma cells and B cells as the primary source of IgA. Autoantigen profiling revealed a diverse repertoire of IgA autoantibodies targeting nuclear, cytoplasmic, and membrane antigens, with levels correlating with disease severity and other clinical manifestations. We identified IgA autoantibodies binding to CD68\u207a macrophages, which induced secretion of TNF, IL-6, and IL-1\u03b2 and upregulated inflammasome and profibrotic pathways. Anti-neutrophil extracellular trap (NET) IgA was elevated in HS and promoted NET formation, establishing a pathogenic feedback loop. NET\u2013IgA immune complexes induced macrophages to secrete CCL18, driving collagen production by fibroblasts and promoting a type I interferon (IFN) gene signature. IgA immune complexes presented by myeloid dendritic cells activated CD4\u207a T cells, triggering IFN-\u03b3 production and further amplifying local inflammation. Notably, supernatants from macrophages exposed to IgA were able to polarize na\u00efve CD4\u207a T cells toward a Th17 phenotype, linking innate immune activation to the expansion of pathogenic adaptive immune responses. Direct exposure of fibroblasts to NET\u2013IgA complexes triggered expression of adhesion molecules, chemokines, and regulators of adaptive immunity. Together, these findings uncover a role for IgA autoantibodies in HS, implicating them as central drivers of chronic inflammation, fibrosis, and immune crosstalk across neutrophils, macrophages, fibroblasts, and T cells.<\/jats:p>","DOI":"10.1038\/s41467-026-70883-5","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:38:11Z","timestamp":1774355891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["IgA autoantibodies promote inflammation, Th17 polarization and fibrotic responses in hidradenitis suppurativa"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7706-1464","authenticated-orcid":false,"given":"Carmelo","family":"Carmona-Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam J.","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Patino-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Ambler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teja","family":"Mallela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-4039","authenticated-orcid":false,"given":"Norio","family":"Hanata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsema K.","family":"Zadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-4574","authenticated-orcid":false,"given":"Kan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginette A.","family":"Okoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel S.","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2968-0815","authenticated-orcid":false,"given":"Mariana J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"70883_CR1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","volume":"73","author":"GB Jemec","year":"2015","unstructured":"Jemec, G. B. & Kimball, A. B. Hidradenitis suppurativa: epidemiology and scope of the problem. J. Am. Acad. Dermatol. 73, S4\u2013S7 (2015).","journal-title":"J. Am. Acad. Dermatol."},{"key":"70883_CR2","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jaci.2022.02.003","volume":"149","author":"KR van Straalen","year":"2022","unstructured":"van Straalen, K. R., Prens, E. P. & Gudjonsson, J. E. Insights into hidradenitis suppurativa. J. Allergy Clin. Immunol. 149, 1150\u20131161 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"70883_CR3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2017.16691","volume":"318","author":"DML Saunte","year":"2017","unstructured":"Saunte, D. M. L. & Jemec, G. B. E. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA 318, 2019\u20132032 (2017).","journal-title":"JAMA"},{"key":"70883_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X19895488","volume":"11","author":"CA Constantinou","year":"2019","unstructured":"Constantinou, C. A., Fragoulis, G. E. & Nikiphorou, E. Hidradenitis suppurativa: infection, autoimmunity, or both? Ther. Adv. Musculoskelet. Dis. 11, 1759720X19895488 (2019).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"70883_CR5","doi-asserted-by":"publisher","first-page":"eaav5908","DOI":"10.1126\/scitranslmed.aav5908","volume":"11","author":"AS Byrd","year":"2019","unstructured":"Byrd, A. S. et al. Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa. Sci. Transl. Med. 11, eaav5908 (2019).","journal-title":"Sci. Transl. Med."},{"key":"70883_CR6","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.12688\/f1000research.17267.1","volume":"7","author":"JW Frew","year":"2018","unstructured":"Frew, J. W., Hawkes, J. E. & Krueger, J. G. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F1000Res. 7, 1930 (2018).","journal-title":"F1000Res"},{"key":"70883_CR7","doi-asserted-by":"publisher","first-page":"e139930","DOI":"10.1172\/jci.insight.139930","volume":"5","author":"JE Gudjonsson","year":"2020","unstructured":"Gudjonsson, J. E. et al. Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis. JCI Insight 5, e139930 (2020).","journal-title":"JCI Insight"},{"key":"70883_CR8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1159\/000512455","volume":"237","author":"Z Wang","year":"2021","unstructured":"Wang, Z., Yan, Y. & Wang, B. gamma-secretase genetics of hidradenitis suppurativa: a systematic literature review. Dermatology 237, 698\u2013704 (2021).","journal-title":"Dermatology"},{"key":"70883_CR9","doi-asserted-by":"publisher","first-page":"e169870","DOI":"10.1172\/jci.insight.169870","volume":"9","author":"MM Lowe","year":"2024","unstructured":"Lowe, M. M. et al. Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa. JCI Insight 9, e169870 (2024).","journal-title":"JCI Insight"},{"key":"70883_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/jdv.16147","volume":"34","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis, C. C. et al. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J. Eur. Acad. Dermatol. Venereol. 34, 846\u2013861 (2020).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"70883_CR11","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/jdv.16264","volume":"34","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis, C. C., Nogueira da Costa, A., Fimmel, S. & Zouboulis, K. C. Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific. J. Eur. Acad. Dermatol Venereol. 34, 1555\u20131563 (2020).","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"70883_CR12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jaci.2022.10.034","volume":"151","author":"R Sabat","year":"2023","unstructured":"Sabat, R. et al. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa. J. Allergy Clin. Immunol. 151, 1015\u20131026 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"70883_CR13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jid.2021.07.187","volume":"142","author":"C Carmona-Rivera","year":"2022","unstructured":"Carmona-Rivera, C. et al. Autoantibodies present in hidradenitis suppurativa correlate with disease severity and promote the release of proinflammatory cytokines in macrophages. J. Invest Dermatol 142, 924\u2013935 (2022).","journal-title":"J. Invest Dermatol"},{"key":"70883_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jid.2022.06.024","volume":"143","author":"CB Oliveira","year":"2023","unstructured":"Oliveira, C. B., Byrd, A. S., Okoye, G. A., Kaplan, M. J. & Carmona-Rivera, C. Neutralizing anti\u2012DNase 1 and \u2012DNase 1L3 antibodies impair neutrophil extracellular traps degradation in hidradenitis suppurativa. J. Invest. Dermatol. 143, 57\u201366 (2023).","journal-title":"J. Invest. Dermatol."},{"key":"70883_CR15","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/j.immuni.2024.11.010","volume":"57","author":"WW Yu","year":"2024","unstructured":"Yu, W. W. et al. Skin immune-mesenchymal interplay within tertiary lymphoid structures promotes autoimmune pathogenesis in hidradenitis suppurativa. Immunity 57, 2827\u201342 e5 (2024).","journal-title":"Immunity"},{"key":"70883_CR16","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.immuni.2024.11.011","volume":"57","author":"C Elkins","year":"2024","unstructured":"Elkins, C. & Li, C. Hidradenitis suppurativa: TLSs take the center stage. Immunity 57, 2712\u20132714 (2024).","journal-title":"Immunity"},{"key":"70883_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409274121","volume":"121","author":"MP Kashyap","year":"2024","unstructured":"Kashyap, M. P. et al. CD2-expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa. Proc. Natl. Acad. Sci. USA. 121, e2409274121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70883_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","volume":"19","author":"Y Sato","year":"2023","unstructured":"Sato, Y., Silina, K., van den Broek, M., Hirahara, K. & Yanagita, M. The roles of tertiary lymphoid structures in chronic diseases. Nat. Rev. Nephrol. 19, 525\u2013537 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"70883_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1116435","volume":"14","author":"L Mes","year":"2023","unstructured":"Mes, L. et al. IgA2 immune complexes selectively promote inflammation by human CD103(+) dendritic cells. Front Immunol. 14, 1116435 (2023).","journal-title":"Front Immunol."},{"key":"70883_CR20","doi-asserted-by":"publisher","first-page":"11132","DOI":"10.3390\/ijms231911132","volume":"23","author":"AV Bos","year":"2022","unstructured":"Bos, A. V. et al. Fcalpha receptor-1-activated monocytes promote B lymphocyte migration and IgA isotype switching. Int. J. Mol. Sci. 23, 11132 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"70883_CR21","doi-asserted-by":"publisher","first-page":"e139932","DOI":"10.1172\/jci.insight.139932","volume":"5","author":"MM Lowe","year":"2020","unstructured":"Lowe, M. M. et al. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-alpha therapy. JCI Insight 5, e139932 (2020).","journal-title":"JCI Insight"},{"key":"70883_CR22","doi-asserted-by":"publisher","first-page":"eaan6619","DOI":"10.1126\/science.aan6619","volume":"358","author":"JJ Bunker","year":"2017","unstructured":"Bunker, J. J. et al. Natural polyreactive IgA antibodies coat the intestinal microbiota. Science 358, eaan6619 (2017).","journal-title":"Science"},{"key":"70883_CR23","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ajpath.2020.07.015","volume":"190","author":"SE Dorraji","year":"2020","unstructured":"Dorraji, S. E. et al. Kidney tertiary lymphoid structures in lupus nephritis develop into large interconnected networks and resemble lymph nodes in gene signature. Am. J. Pathol. 190, 2203\u20132225 (2020).","journal-title":"Am. J. Pathol."},{"key":"70883_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1204777","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis. Front Immunol. 14, 1204777 (2023).","journal-title":"Front Immunol."},{"key":"70883_CR25","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.ajpath.2015.03.012","volume":"185","author":"AR Noort","year":"2015","unstructured":"Noort, A. R. et al. Tertiary lymphoid structures in rheumatoid arthritis: nf-kappab-inducing kinase-positive endothelial cells as central players. Am. J. Pathol. 185, 1935\u20131943 (2015).","journal-title":"Am. J. Pathol."},{"key":"70883_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1084\/jem.20111980","volume":"209","author":"C Lindner","year":"2012","unstructured":"Lindner, C. et al. Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine. J. Exp. Med. 209, 365\u2013377 (2012).","journal-title":"J. Exp. Med"},{"key":"70883_CR27","doi-asserted-by":"publisher","first-page":"e20200275","DOI":"10.1084\/jem.20200275","volume":"217","author":"J Kabbert","year":"2020","unstructured":"Kabbert, J. et al. High microbiota reactivity of adult human intestinal IgA requires somatic mutations. J. Exp. Med. 217, e20200275 (2020).","journal-title":"J. Exp. Med."},{"key":"70883_CR28","first-page":"2557","volume":"30","author":"M Louis","year":"2003","unstructured":"Louis, M., Rauch, J., Armstrong, M. & Fitzcharles, M. A. Induction of autoantibodies during prolonged treatment with infliximab. J. Rheumatol. 30, 2557\u20132562 (2003).","journal-title":"J. Rheumatol."},{"key":"70883_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10067-015-3140-6","volume":"35","author":"JL Vaz","year":"2016","unstructured":"Vaz, J. L., Fernandes, V., Nogueira, F., Arnobio, A. & Levy, R. A. Infliximab-induced autoantibodies: a multicenter study. Clin. Rheumatol. 35, 325\u2013332 (2016).","journal-title":"Clin. Rheumatol."},{"key":"70883_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/02724570050109620","volume":"19","author":"P Oppezzo","year":"2000","unstructured":"Oppezzo, P. et al. Production and functional characterization of two mouse\/human chimeric antibodies with specificity for the tumor-associated Tn-antigen. Hybridoma 19, 229\u2013239 (2000).","journal-title":"Hybridoma"},{"key":"70883_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nbt0901-819","volume":"19","author":"JM Reichert","year":"2001","unstructured":"Reichert, J. M. Monoclonal antibodies in the clinic. Nat. Biotechnol. 19, 819\u2013822 (2001).","journal-title":"Nat. Biotechnol."},{"key":"70883_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn2263","volume":"14","author":"AC Billi","year":"2022","unstructured":"Billi, A. C. et al. Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation. Sci. Transl. Med. 14, eabn2263 (2022).","journal-title":"Sci. Transl. Med"},{"key":"70883_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4049\/jimmunol.2000905","volume":"206","author":"JH Sim","year":"2021","unstructured":"Sim, J. H. et al. Immune cell-stromal circuitry in lupus photosensitivity. J. Immunol. 206, 302\u2013309 (2021).","journal-title":"J. Immunol."},{"key":"70883_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1274270","volume":"14","author":"T Dainichi","year":"2023","unstructured":"Dainichi, T. & Iwata, M. Inflammatory loops in the epithelial-immune microenvironment of the skin and skin appendages in chronic inflammatory diseases. Front Immunol. 14, 1274270 (2023).","journal-title":"Front Immunol."},{"key":"70883_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.854848","volume":"13","author":"P Huang","year":"2022","unstructured":"Huang, P. et al. Identification of biomarkers associated with CD4(+) T-cell infiltration with gene coexpression network in dermatomyositis. Front Immunol. 13, 854848 (2022).","journal-title":"Front Immunol."},{"key":"70883_CR36","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.jid.2020.12.032","volume":"141","author":"KL Chen","year":"2021","unstructured":"Chen, K. L. et al. Myeloid dendritic cells are major producers of IFN-beta in dermatomyositis and may contribute to hydroxychloroquine refractoriness. J. Invest Dermatol 141, 1906\u201314 e2 (2021).","journal-title":"J. Invest Dermatol"},{"key":"70883_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cei.13449","volume":"201","author":"JM Fletcher","year":"2020","unstructured":"Fletcher, J. M., Moran, B., Petrasca, A. & Smith, C. M. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clin. Exp. Immunol. 201, 121\u2013134 (2020).","journal-title":"Clin. Exp. Immunol."},{"key":"70883_CR38","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","volume":"65","author":"C Schlapbach","year":"2011","unstructured":"Schlapbach, C., Hanni, T., Yawalkar, N. & Hunger, R. E. Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa. J. Am. Acad. Dermatol 65, 790\u2013798 (2011).","journal-title":"J. Am. Acad. Dermatol"},{"key":"70883_CR39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12026-020-09149-1","volume":"68","author":"B Li","year":"2020","unstructured":"Li, B. et al. The role of Th17 cells in psoriasis. Immunol. Res. 68, 296\u2013309 (2020).","journal-title":"Immunol. Res"},{"key":"70883_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cei.12670","volume":"183","author":"H Jethwa","year":"2016","unstructured":"Jethwa, H. & Bowness, P. The interleukin (IL)-23\/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment. Clin. Exp. Immunol. 183, 30\u201336 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"70883_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34026-1","volume":"8","author":"A Hammitzsch","year":"2018","unstructured":"Hammitzsch, A. et al. Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases. Sci. Rep. 8, 15645 (2018).","journal-title":"Sci. Rep."},{"key":"70883_CR42","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/gut.2008.163667","volume":"58","author":"S Brand","year":"2009","unstructured":"Brand, S. Crohn\u2019s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn\u2019s disease. Gut. 58, 1152\u20131167 (2009).","journal-title":"Gut"},{"key":"70883_CR43","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/cells13030238","volume":"13","author":"K Hohne","year":"2024","unstructured":"Hohne, K. et al. Pro-fibrotic effects of CCL18 on human lung fibroblasts are mediated via CCR6. Cells 13, 238 (2024).","journal-title":"Cells"},{"key":"70883_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16206","volume":"9","author":"M Hu","year":"2023","unstructured":"Hu, M. et al. M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects. Heliyon 9, e16206 (2023).","journal-title":"Heliyon"},{"key":"70883_CR45","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/bjd.16600","volume":"179","author":"AS Byrd","year":"2018","unstructured":"Byrd, A. S. et al. Collagen deposition in chronic hidradenitis suppurativa: potential role for CD163(+) macrophages. Br. J. Dermatol. 179, 792\u2013794 (2018).","journal-title":"Br. J. Dermatol."},{"key":"70883_CR46","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.1600281","volume":"198","author":"S Kang","year":"2017","unstructured":"Kang, S. et al. BAFF induces tertiary lymphoid structures and positions t cells within the glomeruli during lupus nephritis. J. Immunol. 198, 2602\u20132611 (2017).","journal-title":"J. Immunol."},{"key":"70883_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Signal Transduct. Target Ther. 9, 225 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"70883_CR48","doi-asserted-by":"publisher","first-page":"eaag3358","DOI":"10.1126\/sciimmunol.aag3358","volume":"2","author":"C Carmona-Rivera","year":"2017","unstructured":"Carmona-Rivera, C. et al. Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Sci. Immunol. 2, eaag3358 (2017).","journal-title":"Sci. Immunol."},{"key":"70883_CR49","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep4.1582","volume":"4","author":"C Lammert","year":"2020","unstructured":"Lammert, C. et al. Exploratory study of autoantibody profiling in drug-induced liver injury with an autoimmune phenotype. Hepatol. Commun. 4, 1651\u20131663 (2020).","journal-title":"Hepatol. Commun."},{"key":"70883_CR50","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1172\/JCI136254","volume":"130","author":"A Perez-Diez","year":"2020","unstructured":"Perez-Diez, A. et al. Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia. J. Clin. Invest 130, 5326\u20135337 (2020).","journal-title":"J. Clin. Invest"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70883-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70883-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70883-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:02:10Z","timestamp":1779210130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70883-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70883"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70883-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ASB is a consultant for Sent\u00e9, Inc. GAO is on an Advisory Board for Pfizer, UCB, Eli Lilly, and Novartis and a consultant for Janssen. CJS serves as Secretary of the Board of Directors for HS Foundation, speaker for AbbVie, Novartis and UCB, a consultant for AbbVie, Novartis, UCB, Sanofi, Incyte, InfaRx, Astrazeneca, Navigator Medicines, Moonlake Therapeutics and Elasmogen, and an investigator for Novartis, UCB, Incyte, InflaRx and Astrazeneca. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4469"}}